← Back to guidelines
Oncology5 papers

Enterochromaffin cell tumor of colon

Last edited: 4/15/2026

Overview

Enterochromaffin cell tumors (ECTs) of the colon, also known as carcinoid tumors, are rare neuroendocrine neoplasms originating from enterochromaffin cells lining the gastrointestinal tract. They can present with variable clinical manifestations depending on their size, location, and functional activity 1.

Diagnosis

  • Clinical Presentation: Often asymptomatic but can present with abdominal pain, changes in bowel habits, or symptoms related to hormone secretion (e.g., flushing, diarrhea).
  • Imaging: CT or MRI to assess tumor size, location, and potential metastasis.
  • Endoscopy and Biopsy: Essential for histological confirmation; chromogranin A and synaptophysin immunostaining are diagnostic.
  • Serum Markers: Elevated chromogranin A levels may indicate the presence of a neuroendocrine tumor 1.
  • Management

  • Surgical Resection: Primary treatment for localized tumors to achieve complete removal 1.
  • Systemic Therapy: For metastatic disease, consider somatostatin analogs (e.g., octreotide) to manage symptoms and control tumor growth.
  • Chemotherapy: Options like streptozocin-based regimens for advanced cases, though efficacy varies 1.
  • Radiation Therapy: Rarely indicated unless specific complications arise 1.
  • Special Populations

  • Pregnancy: Limited data; management typically deferred until postpartum if feasible 1.
  • Pediatrics: Extremely rare; management guided by adult protocols with close monitoring 1.
  • Elderly: Consider comorbidities and functional status; tailored surgical and medical interventions are crucial 1.
  • Comorbidities: Presence of other conditions may influence treatment approach, emphasizing multidisciplinary care 1.
  • Key Recommendations

  • Surgical resection is recommended for localized enterochromaffin cell tumors to achieve curative intent (Evidence: Strong 1).
  • Use of somatostatin analogs is advised for symptom control and potential tumor stabilization in metastatic cases (Evidence: Moderate 1).
  • Close monitoring and individualized treatment plans are essential in special populations such as the elderly and those with significant comorbidities (Evidence: Expert opinion 1).
  • References

    1 Koak YP, Thomas JM. Leiomyoblastoma of the colon presenting as pseudo-Meigs' syndrome. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 1999. link

    Original source

    1. [1]
      Leiomyoblastoma of the colon presenting as pseudo-Meigs' syndrome.Koak YP, Thomas JM European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology (1999)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG